Cyclotek https://validator.w3.org/feed/docs/rss2.html Melbourne – Parkville home Product & Services PAH using F18-FBB for cardiac amyloidosis Facilities Contact Us Wellington – New Zealand Melbourne – Bundoora Contract Manufacturing  PET Radiopharmaceuticals Insight & Updates FAQ About Cyclotek Quality & Compliance Product Supply & Logistics Careers Our Network Leadership Team Partnership & Research Vietnam Indonesia Singapore Malaysia Our Story Brisbane – Woolloongabba Sydney – Macquarie University Sydney – Lucas Heights Corporate Head Office  Research & Development Wellinton – New Zealand Cyclotek Expands Radiopharmaceutical Capacity in Queensland: A New Era for Imaging and Therapy Providers National University of Singapore (NUS) Yong Loo Lin School of Medicine – Clinical Imaging Research Centre (CIRC) and Cyclotek Announce Strategic Collaboration to Strengthen Radiopharmaceutical Capability in Singapore and Across ASEAN Brisbane – Woolloongaba CYCLOTEK’S NEW CEO SIGNALS EXPANSION INTO WESTERN AUSTRALIA Logistic & Distribution International Markets Privacy Policy Terms & Conditions Cyclotek Drives Innovation in Radiopharmaceuticals with Cutting-Edge Facilities in Victoria Cyclotek and Duchembio announce APAC extension of the license agreement for [18F]FP-CIT for the diagnosis of neurodegenerative disorders Cyclotek Enables First in Human Company-Sponsored Trial with Terbium-161 Radiopharmaceutical in Australia First Tumorad Dose Administered in World First Clinical Trial Cyclotek Awarded CRC-P Round 16 Grant to Advance Nanobody-Based Theranostic Platform for Cancer Think Pink and Cyclotek – Trip to The Living Centre Cyclotek and the University of Melbourne sign Strategic Partnership Agreement Connecting the Dots: Collaboration and Innovation at EANM’24 Cyclotek Expands Radiopharmaceutical Manufacturing Capacity in Auckland Cyclotek and V-Star Powered Lift Aviation Sign MoU to Make Advanced Air Mobility a Reality in Australia Cyclotek supplies FBB to a Monash University led study promising treatment for dementia New Radiochemical Lab to Support Next-Gen Cancer Treatment